Randy Craven, MD
Show Description +
Randy Craven, MD, reviews phase 3 data from a pair of clinical trials that evaluated the safety and efficacy of the bimatoprost sustained-release implant (Allergan). Dr. Craven discusses the primary endpoint that was met and the safety profile of the implant.
Posted: 10/02/2019
Randy Craven, MD
Randy Craven, MD, reviews phase 3 data from a pair of clinical trials that evaluated the safety and efficacy of the bimatoprost sustained-release implant (Allergan). Dr. Craven discusses the primary endpoint that was met and the safety profile of the implant.
Posted: 10/02/2019
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2019.
Please log in to leave a comment.